Neoplasms, Fibrous Tissue - 25 Studies Found
Recruiting |
: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets : Desmoid Type-fibromatosis : 2015-01-28 : Drug: Toremifene Patients will receive 60 mg daily and then 180 daily in case of progression |
Active, not recruiting |
: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis : Desmoid-Type Fibromatosis : 2014-02-17 :
|
Recruiting |
: Peripheral Primitive Fibromatosis : Peripheral Primitive Fibromatosis : 2013-02-25 : Other: MRI MRI every 3 months during the first year and then every 6 months during the second year and t |
Recruiting |
: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis : Desmoid Tumor : 2010-12-06 : Drug: Sirolimus
|
Withdrawn |
: Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors :
: 2009-09-15 : Drug: Hydroxyurea Patients will take oral hydroxyurea with a starting dose of 20 mg/kg daily. Patients w |
Completed |
: Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis : Desmoid Tumor : 2006-02-06 : Drug: imatinib mesylate |
Completed |
: Radiation Therapy in Treating Patients With Aggressive Fibromatoses : Desmoid Tumor : 2002-02-14 : Radiation: radiation therapy |
Completed |
: Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery :
: 2007-03-20 :
|
Completed |
: Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma :
: 2006-06-07 :
|
Completed |
: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans :
|